MENU
+Compare
AVNS
Stock ticker: NYSE
AS OF
Dec 20, 04:59 PM (EDT)
Price
$16.10
Change
-$0.44 (-2.66%)
Capitalization
919.92M

AVNS Avanos Medical Forecast, Technical & Fundamental Analysis

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

AVNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for AVNS with price predictions
Dec 20, 2024

AVNS sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for AVNS moved below the 200-day moving average on December 09, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 09, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on AVNS as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVNS turned negative on December 17, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AVNS entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNS advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

AVNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.732) is normal, around the industry mean (23.300). P/E Ratio (51.865) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.356) is also within normal values, averaging (43.338).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
AVNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AVNS is expected to report earnings to rise 10.19% to 39 cents per share on February 25

Avanos Medical AVNS Stock Earnings Reports
Q4'24
Est.
$0.40
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.05
Q1'24
Missed
by $0.04
Q4'23
Missed
by $0.03
The last earnings report on October 30 showed earnings per share of 36 cents, beating the estimate of 34 cents. With 1.24M shares outstanding, the current market capitalization sits at 919.92M.
A.I. Advisor
published General Information

General Information

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5405 Windward Parkway
Phone
+1 844 428-2667
Employees
3771
Web
https://www.avanos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DESAX23.120.28
+1.23%
DWS ESG Core Equity A
MTCLX73.470.71
+0.98%
MFS Technology R6
HBLSX14.370.08
+0.56%
Hartford Balanced Income R4
WIGTX13.81-0.02
-0.14%
Seven Canyons World Innovators Instl
VCGEX6.39-0.02
-0.31%
VALIC Company I Emerg Economies

AVNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with OPK. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-2.78%
OPK - AVNS
51%
Loosely correlated
-1.91%
MASS - AVNS
38%
Loosely correlated
+6.19%
FLGT - AVNS
38%
Loosely correlated
-2.19%
UTMD - AVNS
38%
Loosely correlated
-1.71%
VRCDF - AVNS
37%
Loosely correlated
N/A
More